MedPath

Efficacy of Gabapentin on flushing in menopausal wome

Phase 2
Conditions
Flushing.
Menopausal and female climacteric states
Registration Number
IRCT201103011107N4
Lead Sponsor
Jundishapour Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Inclusion criteria :
Elapsing one year of last menstrual phase(LMP), Follicle-stimulating hormone (FSH) more than 40IU/L and not using any drugs that affect on hot flush symptoms.
Exclusion criteria : happening Gabapentin side effects, noncompliance and coexistence of systemic disease

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Flushing severity. Timepoint: Before intervention, 1 month after intervention, 2months later and 3 months later after intervention. Method of measurement: Visual Analoge Scale.
Secondary Outcome Measures
NameTimeMethod
Flushing duration. Timepoint: Before intervention, 1 month after intervention, 2months later and 3 months later after intervention. Method of measurement: Patients notation.
© Copyright 2025. All Rights Reserved by MedPath